NASDAQ
Spruce Biosciences, Inc. (SPRB)
♥ 324 Thanks from members
Spruce Biosciences (SPRB) experiences mixed market sentiment driven by its ongoing development of TA-ERT for Sanfilippo Syndrome Type B, navigating timeline shifts, recent capital raises, and a going concern auditor warning.